Literature DB >> 16917239

Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.

Daniel S Mishkin, William Van Deinse, James M Becker, Francis A Farraye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917239     DOI: 10.1097/00054725-200608000-00020

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  26 in total

Review 1.  Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.

Authors:  Raja K Sivamani; Heidi Goodarzi; Miki Shirakawa Garcia; Siba P Raychaudhuri; Lisa N Wehrli; Yoko Ono; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

2.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

3.  Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries.

Authors:  Aditi I Dagli; Philip J Lee; Catherine E Correia; Christina Rodriguez; Kaustav Bhattacharya; Linda Steinkrauss; Charles A Stanley; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2010-04-13       Impact factor: 4.982

Review 4.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

5.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

6.  Adalimumab for the treatment of Crohn's disease.

Authors:  Andrea Cassinotti; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2008-12

7.  The use of anti-TNFα medications for rheumatologic disease in pregnancy.

Authors:  Megan Eb Clowse
Journal:  Int J Womens Health       Date:  2010-08-09

Review 8.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 9.  Inflammatory bowel diseases and management considerations: fertility and pregnancy.

Authors:  Maria Moscandrew; Sunanda Kane
Journal:  Curr Gastroenterol Rep       Date:  2009-10

10.  Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Authors:  Uma Mahadevan; Douglas C Wolf; Marla Dubinsky; Antoine Cortot; Scott D Lee; Corey A Siegel; Thomas Ullman; Sarah Glover; John F Valentine; David T Rubin; Jocelyn Miller; Maria T Abreu
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-28       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.